|

FID007 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Paclitaxel in Polyethyloxazoline Polymer; FID-007; FID007 (CN); FID 007; Nanoencapsulated Paclitaxel FID-007

Pipeline

Phase 2: 1

Top Sponsors

  • Fulgent Pharma LLC.1

Indications

  • Head and Neck Squamous Cell Carcinoma1
  • Cancer1

Fayetteville, Arkansas1 trial

FID-007 and Cetuximab in Treating Patients With Advanced Head and Neck Squamous Cell Carcinoma

Highlands Oncology - North Hills

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.